Author: WTN News

Oskar Anderson, who administers the state Division of Enterprise Technology, has offered his support for recommendations to improve the success rate of state information technology implementations. The recommendations were contained in a highly critical report issued by the Legislative Audit Bureau....

The Milwaukee Common Council has given an extension to a local company that has been contracted to build its citywide wireless Internet network. Midwest Fiber has until June 7 to finish work in a demonstration area that was supposed to be completed in mid January....

Mithridion, Inc., a Madison-based developer of drugs to slow the progression of Alzheimer's Disease, has secured a second round of venture funding as it continues to develop a drug candidate that would be used in human trials. The company already has demonstrated the efficacy of...

A recently completed audit of information technology projects in key state agencies places the blame squarely on a lack of strong management and oversight on large, high-risk projects. The audit report, which identified 184 IT projects that are expected to cost nearly $300 million, was...

In the first year of his experience as a columnist, Dr. Ogan Gurel has devoted considerable newsprint to technology convergence and its impact on the healthcare industry. In this edition of MedTech Futures, he explains how compatible this trend is with the move to personalized...

Cytochroma, Inc., a company managed by former employees of Bone Care International, has settled a lawsuit filed by Genzyme Corp., the company that acquired Bone Care. The suit, which alleged the theft of intellectual property, was filed in a federal court in Wisconsin. ...

University of San Francisco business professor Oren Harari acknowledges that it's a provocative point, but he believes companies in all industry sectors would do well to take a page from Madonna and Willie Nelson. Before you develop images of businesses executives mimicking either, please note...

Madison's Quintessence Biosciences has taken another step in the development of its lead cancer-fighting drug. The company announced that it has met two preconditions set by the Food and Drug Administration for the drug to be tested on cancer patients, and testing could begin early...